» Articles » PMID: 10208602

Role of Serotonergic Neurons in L-DOPA-derived Extracellular Dopamine in the Striatum of 6-OHDA-lesioned Rats

Overview
Journal Neuroreport
Specialty Neurology
Date 1999 Apr 20
PMID 10208602
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of L-dihydroxyphenylalanine (L-DOPA) on extracellular dopamine (DA) in the striatum was determined by microdialysis in 6-hydroxydopamine (6-OHDA)-lesioned rats treated with and without the serotonergic neurotoxin 5,7-dihydroxytryptamine (5,7-DHT). At the same time the intensity of L-DOPA-induced rotational behavior was assessed. In 6-OHDA-lesioned rats treated with 5,7-DHT, L-DOPA (50 mg/kg, i.p.) increased extracellular DA only to 20% of that measured in animals not treated with 5,7-DHT. Likewise, 6-OHDA-lesioned rats treated with 5,7-DHT exhibited a significantly lower number of L-DOPA-induced rotations. These results suggest that serotonergic terminals in the striatum can convert exogenously administered L-DOPA into DA that can be released into the extracellular space.

Citing Articles

Widespread and Heterologous Effects of L-DOPA on Monoaminergic Tissue Metabolism in Newborn Rats Expressing Air-Stepping.

Barriere G, Pelloquin-Mvogo Z, Boulain M, Khsime I, Bharatiya R, Riquier M Int J Mol Sci. 2025; 26(5).

PMID: 40076918 PMC: 11901079. DOI: 10.3390/ijms26052298.


The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson's disease.

Lipari N, Galfano A, Venkatesh S, Grezenko H, Sandoval I, Manfredsson F Front Neural Circuits. 2024; 18:1463941.

PMID: 39634948 PMC: 11615880. DOI: 10.3389/fncir.2024.1463941.


The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats.

Lorenc-Koci E, Kaminska K, Lenda T, Konieczny J Molecules. 2024; 29(18).

PMID: 39339313 PMC: 11434559. DOI: 10.3390/molecules29184318.


Serotonin as a biomarker of toxin-induced Parkinsonism.

Buchanan A, Mena S, Choukari I, Vasa A, Crawford J, Fadel J Mol Med. 2024; 30(1):33.

PMID: 38429661 PMC: 10908133. DOI: 10.1186/s10020-023-00773-9.


Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists.

Pogorelov V, Martini M, Jin J, Wetsel W, Caron M Biomolecules. 2023; 13(11).

PMID: 38002340 PMC: 10669682. DOI: 10.3390/biom13111658.